✦ LIBER ✦

23 Experience of erlotinib for non-small cell lung cancer (NSCLC) at the Exeter Oncology Centre

✍ Scribed by Minear, F.G.; Ward, A.J.; Dorey, N.E.; Osborne, M.E.; Toy, E.W.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

100 Continuous hyperfractionated acceler

✍ Alip, A.; Toy, E.W. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Chemotherapy of metastatic non-small cel

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Erlotinib for the treatment of non-small

✍ Prashanth Kandaswamy; Meindert Boysen; Carole Longson; Andrew Stevens 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 248 KB

Concurrent chemoradiotherapy (ConCRT) in

✍ Decatris, M.P.; Charalambous, H.; Darby, A.; Christodoulides, G.; Charalambous, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 41 KB

139P ERLOTINIB VERSUS GEFITINIB TREATMEN

✍ Lee, S.Y.; Kim, J.H.; In, K.H.; Kim, H.K.; Kim, S.E.; Kim, Y.K.; Yong, H.S.; Kan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Induction chemotherapy in non-small cell

✍ Johnston, R.; McManus, K.; McGonigle, N.; Stranex, S.; Summers, Y.; Eakin, R.; S 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 40 KB